Experiment 1209907

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationANDERSON,G: CLAVEL,M: SMYTH,J: GIACCONE,G: GRACIA,M: PLANTING,AS: DALESIO,O: KIRKPATRICK,A: MC VIE,G: EORTC:. (1989). PHASE II STUDY OF 9-HYDROXY-2-METHYL-ELLIPTICINIUM ACETATE (ELLIPTICINIUM) IN PATIENTS WITH ADVANCED CARCINOMA OF THE LUNG.. 25(5)
Amount utilized
Compound isolated
Disease45 PATIENTS WITH ADVANCED CARCINOMA OF THE LUNG WERE TREATED WEEKLY FOR 6 WEEKS AND THEREAFTER BIWEEKLY.
Dose amount100.0 MG
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE